Purchases and Sales Made in Q2 2024 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q2 2024. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-128K- 68.0% |
$1.53M - $2.72M
|
60.1K
$1.18M
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-150K- 71.19% |
$1.81M - $3.2M
|
60.9K
$1.19M
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-157K- 85.16% |
$1.89M - $3.35M
|
27.4K
$537K
|
|
Aug 09, 2024
Q2 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-175K- 73.73% |
$2.1M - $3.72M
|
62.3K
$1.22M
|
|
Aug 14, 2024
Q2 2024
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-210K- 48.23% |
$2.52M - $4.46M
|
225K
$4.4M
|
|
Jul 26, 2024
Q2 2024
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
SELL
|
- |
-312K- 11.84% |
$3.75M - $6.65M
|
2.32M
$45.5M
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-363K- 37.59% |
$4.37M - $7.74M
|
603K
$11.8M
|
|
Aug 14, 2024
Q2 2024
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-379K- 30.62% |
$4.55M - $8.07M
|
858K
$16.8M
|
|
Aug 14, 2024
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-451K- 30.08% |
$5.42M - $9.61M
|
1.05M
$20.5M
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-541K- 21.38% |
$6.5M - $11.5M
|
1.99M
$38.9M
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-541K- 21.38% |
$6.5M - $11.5M
|
1.99M
$38.9M
|